Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 45 | 0 | 5 | 0 | €246.30 | €275.25 | 11.754% |
| Neurocrine Bioscience | 42 | 0 | 4 | 0 | €107.00 | €155.89 | 45.692% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.72 | €29.92 | 103.299% |
| Jazz Pharmaceuticals plc | 32 | 0 | 2 | 0 | €98.72 | €183.41 | 85.793% |
| Ultragenyx Pharmaceutical Inc. | 28 | 1 | 3 | 0 | €52.50 | €84.74 | 61.417% |
| Icon plc | 27 | 0 | 5 | 0 | €267.10 | €327.46 | 22.599% |
| United Therapeutics | 28 | 1 | 3 | 0 | €315.20 | €323.16 | 2.524% |
| Halozyme Therapeutics Inc. | 24 | 0 | 3 | 0 | €53.20 | €58.12 | 9.249% |
| Exelixis Inc. | 22 | 0 | 2 | 0 | €24.04 | €26.01 | 8.180% |
| Medpace Holdings Inc | 18 | 0 | 2 | 0 | €330.80 | €416.61 | 25.940% |
| Iovance Biotherapeutics Inc. | 17 | 0 | 0 | 0 | €9.04 | €25.20 | 178.915% |
| Alkermes plc | 18 | 2 | 1 | 0 | €25.20 | €35.60 | 41.288% |
| Xencor Inc. | 16 | 0 | 0 | 0 | €18.70 | €31.38 | 67.809% |
| Repligen Corp. | 14 | 0 | 0 | 0 | €130.60 | €180.11 | 37.910% |
| Charles River Labs Intl | 12 | 0 | 0 | 0 | €187.70 | €247.61 | 31.917% |
| PTC Therapeutics Inc. | 17 | 6 | 5 | 0 | €32.00 | €41.81 | 30.663% |
| QIAGEN NV | 11 | 0 | 0 | 0 | €40.47 | €47.52 | 17.415% |
| Amicus Therapeutics Inc. | 10 | 0 | 2 | 0 | €9.75 | €17.63 | 80.871% |
| Agios Pharmaceuticals Inc. | 11 | 1 | 2 | 0 | €42.60 | €49.07 | 15.194% |
| Taro Pharmaceutical Industries Ltd | 9 | 0 | 0 | 0 | €40.00 | - | - |
| Evotec SE | 10 | 1 | 8 | 0 | €6.06 | €48.50 | 700.991% |
| Bausch Health Companies Inc. | 7 | 0 | 1 | 0 | €7.33 | €12.95 | 76.580% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Emergent Biosolutions Inc. | 8 | 2 | 2 | 0 | €6.01 | €7.45 | 24.007% |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 0 | 0 | €69.50 | €75.37 | 8.447% |